Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

PRPH – ProPhase Labs Inc

ProPhase Labs, Inc.
PRPH
$0.534
Name : ProPhase Labs, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $16,140,790.00
EPSttm : -1.53
finviz dynamic chart for PRPH
ProPhase Labs, Inc.
$0.534
9.49%
$0.056

Float Short %

0.33

Margin Of Safety %

Put/Call OI Ratio

0.02

EPS Next Q Diff

0.17

EPS Last/This Y

EPS This/Next Y

0.67

Price

0.53

Target Price

16

Analyst Recom

1

Performance Q

-32.18

Relative Volume

1.61

Beta

-0.41

Ticker: PRPH




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-01-23PRPH0.49990.020.001428
2025-01-24PRPH0.540.020.001438
2025-01-27PRPH0.4480.020.001438
2025-01-28PRPH0.45340.020.001439
2025-01-29PRPH0.42090.020.001439
2025-01-30PRPH0.41280.020.001439
2025-01-31PRPH0.30.020.001429
2025-02-03PRPH0.2670.020.001448
2025-02-04PRPH0.23510.020.001550
2025-02-05PRPH0.25760.020.001658
2025-02-06PRPH0.2510.020.001659
2025-02-07PRPH0.26070.020.001662
2025-02-10PRPH0.260.020.001667
2025-02-11PRPH0.26010.020.001677
2025-02-12PRPH0.27690.020.001677
2025-02-13PRPH0.3550.010.011684
2025-02-14PRPH0.31920.010.031930
2025-02-18PRPH0.430.010.011941
2025-02-19PRPH0.570.010.022309
2025-02-20PRPH0.59990.010.062697
2025-02-21PRPH0.52510.020.033106
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-01-23PRPH0.4952.9- -1.23
2025-01-24PRPH0.5052.9- -1.23
2025-01-27PRPH0.4552.9- -1.23
2025-01-28PRPH0.4252.9- -1.23
2025-01-29PRPH0.4552.9- -1.23
2025-01-30PRPH0.4252.9- -1.23
2025-01-31PRPH0.2652.9- -1.23
2025-02-03PRPH0.2752.9- -1.23
2025-02-04PRPH0.2452.9- -1.23
2025-02-05PRPH0.2652.9- -1.23
2025-02-06PRPH0.2652.9- -1.23
2025-02-07PRPH0.2652.9- -1.23
2025-02-10PRPH0.2652.9- -1.23
2025-02-11PRPH0.2852.9- -1.23
2025-02-12PRPH0.2952.9- -1.23
2025-02-13PRPH0.3452.9- -1.23
2025-02-14PRPH0.3252.9- -1.23
2025-02-18PRPH0.4352.9- -1.23
2025-02-19PRPH0.5752.9- -1.23
2025-02-20PRPH0.6052.9- -1.23
2025-02-21PRPH0.5352.9- -1.23
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-01-23PRPH0.002.670.48
2025-01-24PRPH0.002.670.48
2025-01-27PRPH0.0013.290.48
2025-01-28PRPH0.0013.290.57
2025-01-29PRPH0.0013.290.57
2025-01-30PRPH0.0013.290.57
2025-01-31PRPH0.0013.290.57
2025-02-03PRPH0.0011.030.57
2025-02-04PRPH0.0011.030.57
2025-02-05PRPH0.0011.030.57
2025-02-06PRPH0.0011.030.45
2025-02-07PRPH0.0011.030.45
2025-02-10PRPH0.0010.340.45
2025-02-11PRPH0.0010.340.45
2025-02-12PRPH0.0010.340.33
2025-02-13PRPH0.0010.340.33
2025-02-14PRPH0.0010.340.33
2025-02-18PRPH0.0012.110.33
2025-02-19PRPH0.0012.110.33
2025-02-20PRPH0.0012.110.33
2025-02-21PRPH0.0012.110.33
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.35

Avg. EPS Est. Current Quarter

-0.24

Avg. EPS Est. Next Quarter

-0.18

Insider Transactions

Institutional Transactions

12.11

Beta

-0.41

Average Sales Estimate Current Quarter

5

Average Sales Estimate Next Quarter

2

Fair Value

Quality Score

23

Growth Score

37

Sentiment Score

51

Actual DrawDown %

96.7

Max Drawdown 5-Year %

-98.4

Target Price

16

P/E

Forward P/E

PEG

P/S

1.25

P/B

0.27

P/Free Cash Flow

EPS

-1.5

Average EPS Est. Cur. Y​

-1.23

EPS Next Y. (Est.)

-0.56

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-217.64

Relative Volume

1.61

Return on Equity vs Sector %

-92

Return on Equity vs Industry %

-83.3

EPS 1 7Days Diff

-0.3

EPS 1 30Days Diff

-0.31

EBIT Estimation

ProPhase Labs, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 113
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.
stock quote shares PRPH – ProPhase Labs Inc Stock Price stock today
news today PRPH – ProPhase Labs Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PRPH – ProPhase Labs Inc yahoo finance google finance
stock history PRPH – ProPhase Labs Inc invest stock market
stock prices PRPH premarket after hours
ticker PRPH fair value insiders trading